Hepatitis C assay utilizing recombinant antigens
US6172189A · kind A · utility
20Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 1997 |
| Grant date | Jan 9, 2001 |
| Priority date | — |
| Expiry date | Jun 2, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides unique recombinant antigens representing distinct antigenic regions of the Hepatitis C Virus (HCV) genome which can be used as reagents for the detection of antibodies and antigen in body fluids from individuals exposed to HCV. The present invention also provides an assay for detecting the presence of an antibody to an HCV antigen in a sample by contacting the sample with the recombinant antigens. Preferred assay formats include a screening assay, a confirmatory assay, a competition or neutralization assay and an immunodot assay.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.